CPX-351

• Description:

  CPX-351 (Vyxeos) is a liposomal encapsulant of cytarabine and Zoerythromycin with potential antitumor activity and can be used in the study of acute myeloid leukemia.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  770.74

• Molecular Formula:

  C36H42N4O15

• Notes:

  Research use only, not for human use.

• Receptor:

  Others

• CAS Number:

  1256639-86-7